These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8049886)
1. Use of interferon in the treatment of chronic viral hepatitis. Gibas AL Gastroenterologist; 1993 Jun; 1(2):129-42. PubMed ID: 8049886 [TBL] [Abstract][Full Text] [Related]
2. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B. Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911 [TBL] [Abstract][Full Text] [Related]
3. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study. Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058 [TBL] [Abstract][Full Text] [Related]
4. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial. Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905 [TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications. Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839 [TBL] [Abstract][Full Text] [Related]
6. Therapy of hepatitis C: re-treatment with alpha interferon. Alberti A; Chemello L; Noventa F; Cavalletto L; De Salvo G Hepatology; 1997 Sep; 26(3 Suppl 1):137S-142S. PubMed ID: 9305679 [TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up. Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847 [TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of interferon-alpha therapy for chronic hepatitis B. Di Bisceglie AM J Hepatol; 1995; 22(1 Suppl):65-7. PubMed ID: 7602080 [TBL] [Abstract][Full Text] [Related]
10. Therapy of hepatitis C: patients with normal aminotransferase levels. Marcellin P; Lévy S; Erlinger S Hepatology; 1997 Sep; 26(3 Suppl 1):133S-136S. PubMed ID: 9305678 [TBL] [Abstract][Full Text] [Related]
11. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. Gil B; Qian C; Riezu-Boj JI; Civeira MP; Prieto J Hepatology; 1993 Nov; 18(5):1050-4. PubMed ID: 8225209 [TBL] [Abstract][Full Text] [Related]
12. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189 [TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha. Truong BX; Seo Y; Kato M; Hamano K; Ninomiya T; Katayama M; Kato H; Yano Y; Hayashi Y; Kasuga M Int J Mol Med; 2005 Aug; 16(2):279-84. PubMed ID: 16012762 [TBL] [Abstract][Full Text] [Related]
14. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up]. Liu DL; Luo KX; Feng XR; Fu QX; Hou JL Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996 [TBL] [Abstract][Full Text] [Related]
16. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C. Laghi V; Toccaceli F; Rosati S; Monini A; Grimaldi M; Foglianti G; Canova N; Palazzini E Hepatogastroenterology; 1997; 44(16):1182-6. PubMed ID: 9261621 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C. Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559 [TBL] [Abstract][Full Text] [Related]
18. Interferons in the management of viral hepatitis. Zein NN Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057 [TBL] [Abstract][Full Text] [Related]